+91 80 2808 2808

Kiran Mazumdar-Shaw elected as Member of the National Academy of Engineering, U.S.

  • Posted by: BIOCON

Bengaluru, Karnataka, India, February 8, 2019

Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon Ltd has been elected as a member of the prestigious U.S.-based National Academy of Engineering (NAE) for her contribution to the development of affordable biopharmaceuticals and the biotechnology industry in India. She is the first woman from India to get this prestigious global honour.

Election to the NAE is among the highest professional distinctions accorded to an engineer. Academy membership honors those who have made outstanding contributions to engineering research, practice, or education, and to the pioneering of new and developing fields of technology, making major advancements in traditional fields of engineering, or developing/implementing innovative approaches to engineering education.

The NAE elected 86 new members and 18 foreign members to its 2019 class.

Individuals in the newly elected class will be formally inducted during a ceremony at the NAE’s annual meeting in Washington, D.C., on Oct. 6, 2019.

Commenting on her election, Ms Kiran Mazumdar-Shaw said: “This is a huge honour. I am humbled to be elected to an institution that provides the leadership and expertise for numerous projects focused on the relationships between engineering, technology, and the quality of life. Science and Technology are fundamental to solving some of the biggest challenges facing the world today and the NAE is playing a pivotal role in encouraging the kind of research and innovation that can make a global impact by pushing the boundaries of science and engineering.”

Ms Mazumdar-Shaw is a well-regarded global influencer and has been named among TIME magazine’s 100 most influential people in the world. Her pioneering efforts in biotechnology have drawn global recognition for both the Indian industry and Biocon, Asia’s premier biopharmaceutical company.

She was elected full-term member of the Board of Trustees of the MIT, U.S. in 2018. She has been given the AWSM Award for Excellence in 2017 by the Feinstein Institute for Medical Research and the Chemical Heritage Foundation conferred her with the Othmer Gold Medal in 2014. She has received the highest French distinction, Knight of the Legion of Honour, in 2016 and the Global Economy Prize for Business in 2014 from the Kiel Institute for the World Economy, Germany, for her outstanding contribution and dedication to the biosciences and research field globally.

She is the proud recipient of India’s two highest civilian honours – Padma Shri in 1989 and Padma Bhushan in 2005.

She has featured in the Forbes’ list of ‘World’s 100 Most Powerful Women’; Scientific American’s ‘The Worldview 100 List’ of most influential visionaries; and Fortune’s ‘Top 25 Most Powerful Women in Asia-Pacific’. She was ranked No. 1 in the Business Captains category in the Medicine Maker Power List 2018, an index of the 100 most influential people across the globe in the field of medicine.

About National Academy of Engineering
The National Academy of Engineering (NAE), a U.S.-based private, independent, non-profit institution, is part of The National Academies of Sciences, Engineering, and Medicine. The NAE has more than 2,000 peer-elected members and foreign members, senior professionals in business, academia, and government who are among the world’s most accomplished engineers.

Author: BIOCON
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>